Roivant Sciences Change in Other Liabilities remained flat by 0.0% to -$252.00K in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 230.4%, from $193.25K to -$252.00K. Over 3 years (FY 2022 to FY 2025), Change in Other Liabilities shows a downward trend with a -22.3% CAGR.
An increase suggests the company is deferring obligations or increasing long-term liabilities, providing a source of cash.
Captures the net change in non-current or miscellaneous liabilities not classified as debt or standard accounts payable....
Commonly used to track non-operating liability fluctuations across industrial peers.
change_in_other_liabilities| FY'22 | FY'23 | FY'24 | FY'25 | |
|---|---|---|---|---|
| Value | $2.15M | -$2.39M | $773.00K | -$1.01M |
| YoY Change | — | -211.1% | +132.4% | -230.4% |